ESR1 and breast cancer: In this study, although high BCL1 expression was significantly associated with favorable clinicopathologic features such as ER-positive, PR-positive, and low histologic grade, BCL1 expression had no prognostic effect in unselected breast cancers as well as in HRc-positive or HRc-negative breast cancers.